Analgosedation in patients with acute respiratory failure on noninvasive ventilation: is it truly safe?
2024

Safety of Sedation in Patients with Acute Respiratory Failure on Noninvasive Ventilation

Sample size: 433357 publication Evidence: moderate

Author Information

Author(s): Guerrero-Gutiérrez Manuel Alberto, Reyes-Monge Rafael Alfonso, Rodríguez-Guevara Ignacio, Escarramán-Martínez Diego, Pérez-Nieto Orlando Rubén

Primary Institution: Department of Anesthesiology and Intensive Care Unit, Baja Medical Center, Tijuana, Baja California, Mexico

Hypothesis

Is analgosedation truly safe for patients with acute respiratory failure on noninvasive ventilation?

Conclusion

The study highlights the potential risks associated with sedation during noninvasive ventilation for patients with acute respiratory failure.

Supporting Evidence

  • The incidence of bradycardia is greater when dexmedetomidine is used during NIV.
  • 26.7% of patients with ARF received sedation or analgesia during NIV.
  • Opioids alone were associated with lower risk of intubation and death.

Takeaway

This study looks at how giving medicine to help patients relax during breathing support can sometimes cause more problems than it solves.

Methodology

The study analyzed a large retrospective cohort of patients with acute respiratory failure receiving noninvasive ventilation.

Potential Biases

Potential bias due to the observational design and reliance on existing data.

Limitations

The study is observational in nature, which may limit the ability to establish causation.

Participant Demographics

Patients with acute respiratory failure due to various conditions including obstructive lung disease and ARDS.

Statistical Information

P-Value

p<0.001

Confidence Interval

95% CI 1.03–3.49

Statistical Significance

p<0.001

Digital Object Identifier (DOI)

10.1186/s44158-024-00221-y

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication